SUNVENIZ XL |
VAXALIN XL |
VEXARIN XL |
RANFAXINE XL |
EFFEXOR |
ALVENTA XL |
VENLABLUE XL |
EFEXOR |
FORAVEN XL |
TIFAXIN XL |
VENLANEO XL |
RODOMEL XL |
VENSIR XL |
VIEPAX |
MENTAVEN XL |
TONPULAR XL |
BONILUX XL |
VENLADEX XL |
VENAXX XL |
TRIXAT XL |
AMPHERO XL |
DEPEFEX XL |
TARDCAPS XL |
WINFEX XL |
EFEXOR XL |
VENLAFAXINE |
VENLALIC XL |
VIEPAX XL |
POLITID XL |
TREVILOR |
WY-45030 |
VENLAFAXIN |
ELAFAX |
EFECTIN |
VENLAFEXINE |
1-[2-(DIMETHYLAMINO)-1-(4-METHOXYPHENYL)ETHYL]CYCLOHEXAN-1-OL |
EFFEXOR® |
rxcui:39786 |
drugbank:00285 |
pubchem.compound:5656 |
chembl:CHEMBL637 |
chemidplus:93413-69-5 |
Drug Categories | serotonin and noradrenaline reuptake inhibitors |
Drug Categories | fatty alcohols |
Drug Categories | cyclohexanols |
FDA Approval | approved |
Drug Class | Small Molecule |
Drug Indications | antidepressant |
Drug Class | antidepressive agents, second-generation |
Year of Approval | 1993 |
Drug Categories | agents producing tachycardia |
Drug Categories | agents that reduce seizure threshold |
Drug Categories | bcrp/abcg2 inducers |
Drug Categories | central nervous system depressants |
Drug Categories | combined inhibitors of serotonin/norepinephrine reuptake |
Drug Categories | cytochrome p-450 cyp2d6 inhibitors (weak) |
Drug Categories | cytochrome p-450 cyp3a substrates |
Drug Categories | cytochrome p-450 enzyme inhibitors |
Drug Categories | cytochrome p-450 substrates |
Drug Categories | drugs that are mainly renally excreted |
Drug Categories | hypoglycemia-associated agents |
Drug Categories | norepinephrine uptake inhibitors |
Drug Categories | p-glycoprotein inhibitors |
Drug Categories | p-glycoprotein substrates |
Drug Categories | potential qtc-prolonging agents |
Drug Categories | qtc prolonging agents |
Drug Categories | serotonergic drugs shown to increase risk of serotonin syndrome |
Drug Categories | serotonin agents |
inhibitor (inhibitory) |
Trial Name | Effexor |
Novel drug target | Established target |
Specific Action of the Ligand | Inhibition |
inhibitor (inhibitory) |
Specific Action of the Ligand | Inhibition |
Endogenous Drug? | False |
Direct Interaction? | True |
93413-69-5 | CAS Number |
Act Venlafaxine XR | Drug Brand |
Apo-venlafaxine XR | Drug Brand |
Drug Type | small molecule |
Drug Groups | approved |
Drug Categories | agents producing tachycardia |
Drug Indications | antidepressant |
Drug Class | Small Molecule |
FDA Approval | approved |
Year of Approval | 1993 |
Drug Class | antidepressive agents, second-generation |
C1278 | NCI drug code |
D0P1UX | TTD Drug ID |